Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09SIK
|
|||
| Former ID |
DIB002736
|
|||
| Drug Name |
Azaribine
|
|||
| Synonyms |
AZARIBINE; Triazure; Triacetyl-6-azauridine; Azaribinum; Azaribina; 2169-64-4; 6-Azaribine; TA-Azur; Azaribin; 2',3',5'-Tri-O-acetyl-6-azauridine; 6-Azauridine triacetate; 6-Azauridin-triacetat; 6-Azauridine 2',3',5'-triacetate; Azaribinum [INN-Latin]; 6-AzUR-TA; Azaribina [INN-Spanish]; 2',3',5'-Triacetyl-6-azauridine; CB-304; UNII-K1U80DO9EB; 6-Azauracilribosid-triacetat; K1U80DO9EB; Azaribine [USAN:INN:BAN]; MLS000069488; EINECS 218-515-6; Azauridine triacetate; 2-beta-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triace
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H17N3O9
|
|||
| Canonical SMILES |
CC(=O)OCC1C(C(C(O1)N2C(=O)NC(=O)C=N2)OC(=O)C)OC(=O)C
|
|||
| InChI |
1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1
|
|||
| InChIKey |
QQOBRRFOVWGIMD-OJAKKHQRSA-N
|
|||
| CAS Number |
CAS 2169-64-4
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:88272
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.